Maternal care for anti-D [Rh] antibodies, second trimester (not applicable or unspecified)
ICD-10 O36.0120 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, second trimester (not applicable or unspecified).
Maternal care for anti-D [Rh] antibodies during the second trimester is crucial for managing potential fetal complications arising from Rh incompatibility. This condition occurs when an Rh-negative mother carries an Rh-positive fetus, leading to the mother's immune system producing antibodies against the fetal red blood cells. If untreated, this can result in hemolytic disease of the newborn (HDN), characterized by fetal anemia, jaundice, and in severe cases, fetal distress or intrauterine growth restriction (IUGR). Monitoring during this period includes regular ultrasounds to assess fetal growth and well-being, as well as blood tests to evaluate the mother's antibody levels. The management may involve administering Rh immunoglobulin (RhoGAM) to prevent antibody formation and close monitoring of fetal health to mitigate risks associated with fetal anemia and distress. Proper documentation of maternal antibody status, fetal assessments, and any interventions is essential for accurate coding and care continuity.
Detailed records of maternal antibody status, fetal assessments, and any interventions performed.
Routine monitoring of an Rh-negative mother with an Rh-positive fetus, management of fetal distress due to anemia.
Ensure accurate coding of any additional complications or interventions related to Rh incompatibility.
Comprehensive documentation of high-risk pregnancy management, including ultrasound findings and maternal-fetal assessments.
Management of severe fetal anemia or IUGR due to Rh incompatibility.
Focus on detailed fetal monitoring and interventions to prevent adverse outcomes.
Used to monitor Rh-negative mothers for anti-D antibodies.
Document the reason for testing and results.
Ensure that results are communicated to the obstetric care team.
Coding O36.0120 is essential for tracking maternal care related to Rh incompatibility, which can have serious implications for fetal health. Accurate coding ensures appropriate management and intervention strategies are documented and reimbursed.
